Abstract
BackgroundTissue kallikrein (TK) plays an important role in the kallikrein-kinin system. Its protective role has been demonstrated in traumatic brain injury (TBI). We attempted to determine relationship between serum TK levels and trauma severity in addition to clinical outcome in TBI. MethodsWe recruited 112 patients with severe TBI (Glasgow coma scale score < 9) and 112 controls. We configured 2 multivariate models to assess the relationship between serum TK levels and 30-day death. Its prognostic predictive ability was analyzed under receiver operating characteristic curve. ResultsTK levels were significantly lower in patients than in controls (median 0.148 mg/l, the upper - lower quartiles 0.121–0.185 vs. median 0.258 mg/l, the upper - lower quartiles 0.207–0.342, P < 0.001). TK levels were closely and positively correlated with Glasgow coma scale score (r = 0.550). TK levels <0.148 mg/l independently predicted 30-day mortality with odds ratio value of 4.752 (95% confidence interval (CI), 1.166–19.367) and 30-day overall survival with hazard ratio value of 3.698 (95% CI, 1.026–13.333). TK levels significantly discriminated 30-day mortality with area under curve of 0.822 (95% CI, 0.738–0.887). ConclusionsSerum TK can represent a potential predictor of clinical outcome in TBI patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call